NICE has recommended dupilumab for adults with uncontrolled COPD and raised eosinophils, citing fewer exacerbations and ...

NICE has estimated that around 40% of people with COPD have elevated blood levels of eosinophils and, if half the eligible ...

A biologic injection that reduces chronic obstructive pulmonary disease (COPD) flare-ups by around a third has been approved for use on the NHS in England and Wales. The National Institute for Health ...

Dupilumab, a simple pre-filled pen that people inject themselves with every two weeks, is the first biologic that targets both the symptoms of COPD and an underlying cause of the disease. It brings ...

NICE has approved the first targeted treatment for chronic obstructive pulmonary disease (COPD), offering a new option to up ...

University Hospitals Samaritan Medical Center welcomes two providers who join an expert team to treat diseases like COPD, ...

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended Dupixent ...

Sanofi and Regeneron’s Dupixent (dupilumab) has received positive final draft guidance from the National Institute for Health ...

COPD and gastrointestinal diseases have a significant bidirectional association, with depressive symptoms serving as a key mediator.

Recent developments of interest in cardiovascular medicine ...

For each year of increase in menopausal age, COPD risk was reduced by 1.2%, and current smokers reached menopause 1.402 years earlier than never smokers. Menopausal age has a strong association with ...